SATURDAY 21 OCTOBER 2023
Plenary Session 2
Chairs: t.b.c.
08:30
PS2.1 fungi and Alzheimer’s
09:00
PS2.2 fungi and Cancer
10:00
Coffee break
Meet the expert session [1 topic, 2 speakers]
10:15
M1 How I treat in Mycology?
Johan Maertens, Belgium, FECMM & Darius Armstrong-Jones, United Kingdom, FECMM
10:15
M2 Fungi and bacteria
Gordon Ramage, United Kingdom, FECMM & Francoise Botterel, France, FECMM
10:15
M3 Mucormycosis in routine practice Epidemiological trends of Mucormycosis in Europe, comparison with other continents
Anna Skiada, Greece & Laurence Millon, France
10:15
M4 Candidiasis of central nervous system in paediatrics - Hematogenous meningoencephalitis in premature neonates
Alessio Mesini, Italy & Charalampos Antachopoulos , Greece
10:15
M5 Antifungal Stewardship
Marisa Miceli, United States, FECMM & Diamantis Kofteridis, Greece
11:00
Poster session
12:00
Lunch break
12:30
Sponsored Integrated Symposium 2
More information will follow soon
14:15
Parallel Symposia 5-9
Symposium 5 Candida auris: Antifungal resistance and its origin and spread.
Chairs: t.b.c.
14:15
S05.1 International spread and endemicity
Nelesh Govender, South-Africa, FECMM
14:35
S05.2 Antifungal and pan-antifungal resistance and the role of new antifungals
Luis Ostrosky-Zeichner, United States, FECMM
14:55
S05.3 Origin and environmental detection of C. auris
Anuradha Chowdhary, India, FECMM
15:15
S05.3 Diagnostic challanges
Vishnu Chaturvedi, United States, FECMM
15:15
S05.4 selected abstract
Symposium 6 YECMM session clinical mycology
Chairs: t.b.c.
14:15
S06.1 Trends in antifungal treatment
Rosanne Sprute, Germany
14:30
S06.2 Trends in mycological diagnostics
Matthias Egger, Austria, FECMM
14:45
S06.3 selected abstract
15:00
S06.4 selected abstract
15:15
S06.5 selected abstract
15:30
S06.6 selected abstract
Symposium 7: The respiratory mycobiome
Chairs: t.b.c.
14:15
S07.1 The lung microbiome : Recent concept with novel functions in Health and Disease
Laurence Delhaes, France
14:35
S07.2 The respiratory mycobiome in critically ill COVID-19 patients
Danielle Weaver, United Kingdom
14:55
S07.3 The respiratory mycobiome during cystic fibrosis: where do we stand
Cécile Angebault, France
15:15
S07.4 Selected abstract
Symposium 8 Clinic meets Pharmacology: Antifungal treatment
Chairs: t.b.c.
14:15
S08.1 Is TDM of antifungals and other drugs a way to individualized therapy?
Russell Lewis, Italy
14:35
S08.2 Drug-drug interactions of antifungal and haematological agents - is it relevant in the clinical routine?
David Andes, United States, FECMM
14:55
S08.3 TDM of antifungals during ECMO and/or renal replacement - is it improving outcome of critically ill patients?
Roger Bruggeman, the Netherlands, FECMM
15:15
S08.4 selected abstract
Symposium 9 Fungal Infections of Combat Wounds
Chairs: Tom Walsh
14:15
S09.1 Fungal Infections of Combat Wounds: Burden, Epidemiology, and Mycology
14:45
S09.2 Laboratory Diagnosis of Fungal Infections of Combat Wounds
Riina Richardson, United Kingdom, FECMM
15:15
S09.3 Pathogenesis, Preclinical Models, and Treatment of Combat Wound Mucormycosis
Alex Bobrov, United States
15:45
Coffee break
16:15
Parallel Symposia 10- 13
Symposium 10 YECMM session Basic Research
Chairs: Sarah Delliére & Lore vanderbeke
16:15
S10.1 Humoral immunity against Aspergillus
Sarah Delliére , France
16:30
S10.2 Epithelial responses against Aspergillus
Lore vanderbeke, Belgium
16:45
S10.3 selected abstract
17:00
S10.4 selected abstract
17:15
S10.5 selected abstract
17:30
S10.6 selected abstract
Symposium 11 Controversies in medical mycology - [in cooperation with MSG]
Chairs: t.b.c.
16:15
S11.1 Should immediate removal of catheters and eye exams still be recommended for all patients with candidemia?
Peter Pappas, United States
16:35
S11.2 Shorter course of antifungal therapy for candidemia and aspergillosis?
Ilan Schwartz, Canada, FECMM
16:55
S11.3 should stable continue to be failure in mycology clinical trials?
Oliver Cornely, Germany, FECMM
17:15
S11.4 selected abstract
Symposium 12 Host pathogen interaction in aspergillosis
Chairs: t.b.c.
16:15
S12.1 Aspergillus host interactions in viral associated pulmonary aspergillosis
Simon Feys, Belgium
16:35
S12.2 Role of inflammasomes/pyro ptosis and PANoptosis during fungal infection
Benoit Briard, France
16:55
S12.3 Host response to aspergillus
Georgios Chamilos, Greece
17:15
S12.4 Selected abstract
Symposium 13 Environment and Fungi / Susceptibility - Health Impacts and Control
Chairs: t.b.c.
16:15
S13.1 Recreational and drinking water - facts and regulation
Joao Brandao, Portugal
16:35
S13.2 Control of airborne and high temperature- waterborne fungal infections in hospitals
Joseph Meletiadis, Greece, FECMM
16:55
S13.3 Climate change and its impact on human fungal infections
Sevtap Arikan-Akdagli, Turkey, FECMM
17:10
S13.4 Selected abstraact
18:00
Sponsored Integrated Symposium 3
More information will follow soon
19:30
Sponsored reception